Sonoma Pharmaceuticals Inc SNOA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $1.26
- Day Range
- $1.22–1.29
- 52-Week Range
- $0.85–6.92
- Bid/Ask
- $1.23 / $1.24
- Shares Outstanding
- 4.79M
- Market Cap
- $6.03M
- Volume/Avg
- 101,758 / 242,204
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.11
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 260
- Website
- https://www.sonomapharma.com
Valuation
|
Metric
|
SNOA
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.71 |
Price/Sales | 0.11 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
SNOA
|
|---|---|
Quick Ratio | 1.62 |
Current Ratio | 2.50 |
Interest Coverage | — |
Quick Ratio
SNOA
Profitability
|
Metric
|
SNOA
|
|---|---|
Return on Assets (Normalized) | −21.07% |
Return on Equity (Normalized) | −78.22% |
Return on Invested Capital (Normalized) | −67.41% |
Return on Assets
SNOA
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|^##H^tx | LOCK|@F%%x | $69B | |||
| Haleon PLC ADR
HLN
| LOCK|@@>$%dV | LOCK|WRz | $43B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| LOCK|^X>$WPw | LOCK|>&&@^ | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|$>$!%hP | LOCK|C%C | $32B | |||
| Viatris Inc
VTRS
| LOCK|L!yJSq% | LOCK|r!p | $19B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|@n! | LOCK|X>@ | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|m>BW^s@ | LOCK|y^ | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|?$Ml%#T | LOCK|k?B | $8B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|%mmTRB | LOCK|%&vw | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|!%lTkc | LOCK|^! | $1B |
United States